mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.4 |
mRNA |
BRD8958 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.4 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |